IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 159 filers reported holding IMPAX LABORATORIES INC in Q3 2013. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $3,434,000 | -19.4% | 162,047 | -38.8% | 0.07% | -22.4% |
| Q2 2017 | $4,262,000 | -11.6% | 264,725 | -30.5% | 0.08% | -27.4% |
| Q1 2017 | $4,819,000 | +232.1% | 380,962 | +247.9% | 0.12% | +125.0% |
| Q4 2016 | $1,451,000 | -24.7% | 109,512 | +34.6% | 0.05% | -13.3% |
| Q3 2016 | $1,928,000 | +295.9% | 81,340 | +381.6% | 0.06% | +275.0% |
| Q2 2016 | $487,000 | -75.0% | 16,889 | -79.2% | 0.02% | -63.6% |
| Q3 2014 | $1,947,000 | +302.3% | 81,142 | +403.2% | 0.04% | +175.0% |
| Q2 2014 | $484,000 | -72.6% | 16,125 | -75.9% | 0.02% | -69.2% |
| Q1 2014 | $1,769,000 | -53.2% | 66,949 | -55.5% | 0.05% | -45.3% |
| Q4 2013 | $3,778,000 | -17.4% | 150,284 | -32.6% | 0.10% | -6.9% |
| Q3 2013 | $4,575,000 | -3.3% | 223,068 | -5.9% | 0.10% | -20.3% |
| Q2 2013 | $4,729,000 | – | 237,032 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 423,161 | $13,406,000 | 7.47% |
| Aravt Global | 2,300,000 | $72,864,000 | 5.43% |
| Slate Path Capital LP | 2,330,000 | $73,814,000 | 5.16% |
| Orbimed Advisors | 6,678,000 | $211,559,000 | 2.02% |
| Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
| Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
| Penn Capital Management Company, LLC | 709,045 | $22,463,000 | 0.94% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 250,000 | $7,920,000 | 0.79% |
| NEW AMSTERDAM PARTNERS LLC/NY | 276,169 | $8,749,000 | 0.76% |
| Matarin Capital Management, LLC | 52,932 | $1,676,886,000 | 0.74% |